4.7 Review

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19

期刊

出版社

MDPI
DOI: 10.3390/ijms23031716

关键词

adaptive immunity; autoimmunity; cellular stress; cytokines; interferons; post-COVID-19 syndrome; receptors; SARS-CoV-2; superantigens; systemic inflammation

资金

  1. RFBR
  2. NSFC [21-51-55003]
  3. Government contract of the Institute of Immunology and Physiology

向作者/读者索取更多资源

The review consolidates research findings on the molecular mechanisms, virulence, and pathogenicity characteristics of SARS-CoV-2, the causative agent of COVID-19, and their relevance to the different stages of acute viral infection. It highlights the importance of the invasion stage, primary blockade of antiviral innate immunity, engagement of adaptive immune responses, and acute and long-term complications of COVID-19.
The review aims to consolidate research findings on the molecular mechanisms and virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and their relevance to four typical stages in the development of acute viral infection. These four stages are invasion; primary blockade of antiviral innate immunity; engagement of the virus's protection mechanisms against the factors of adaptive immunity; and acute, long-term complications of COVID-19. The invasion stage entails the recognition of the spike protein (S) of SARS-CoV-2 target cell receptors, namely, the main receptor (angiotensin-converting enzyme 2, ACE2), its coreceptors, and potential alternative receptors. The presence of a diverse repertoire of receptors allows SARS-CoV-2 to infect various types of cells, including those not expressing ACE2. During the second stage, the majority of the polyfunctional structural, non-structural, and extra proteins SARS-CoV-2 synthesizes in infected cells are involved in the primary blockage of antiviral innate immunity. A high degree of redundancy and systemic action characterizing these pathogenic factors allows SARS-CoV-2 to overcome antiviral mechanisms at the initial stages of invasion. The third stage includes passive and active protection of the virus from factors of adaptive immunity, overcoming of the barrier function at the focus of inflammation, and generalization of SARS-CoV-2 in the body. The fourth stage is associated with the deployment of variants of acute and long-term complications of COVID-19. SARS-CoV-2's ability to induce autoimmune and autoinflammatory pathways of tissue invasion and development of both immunosuppressive and hyperergic mechanisms of systemic inflammation is critical at this stage of infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据